Institute of Biomedical and Biomolecular Science
The Institute of Biomedical and Biomolecular Science (IBBS) serves as a focus for multidisciplinary research in biomedical sciences, including both fundamental studies and applied research
The Institute of Biomedical and Biomolecular Science (IBBS) serves as a focus for multidisciplinary research in the biomedical sciences, including both fundamental studies and applied research in the molecular biosciences.
IBBS is funded by external research grants totalling over £10m, principally from the Research Councils (BBSRC, EPSRC, MRC), the Wellcome Trust and more specialised biomedical charities, the European Union and the Pharmaceutical Industry. There are outstanding facilities for research at the molecular and cellular levels.
The Institute comprises staff from the School of Biological Sciences and the School of Pharmacy and Biomedical Sciences. Our research is organised into four groups, with substantial interaction between them, and many research projects are collaborative.
Stop press: REF 2014 Results
In the last Research Assessment Exercise (RAE 2008), 55% of our research was recognised as being world-leading (4*) or internationally excellent (3*). The Grade Point Average (GPA) of our submission was 2.50.
In REF2014, we have built upon that research excellence, both in the overall quality of our research and in its impact, with 25 staff submitted (23.8 FTE):-
- 90% of our research overall was rated 4*/3* (world-leading or internationally excellent), up from 55% in RAE 2008;
- 100% of our research impact was classified as 4*/3*;
- Our overall GPA for the submission increased from 2.50 to 3.12;
- We were ranked in the top 20 of 94 submissions (% 4*/3* research activity);
- Within the University Alliance group, we ranked 3rd out of 25 (% 4*/3* research activity).
Professor Geoff Kneale, who led the IBBS submission, commented:
"This is an outstanding result for us, and reflects greatly on the efforts of all academic and research staff associated with the Institute. This places us in the top 15 universities in England in our subject area. I am particularly pleased that building on our excellent result in 2008, the proportion of our research classified as world-leading (4*) has increased by 60%. We have achieved this, not by bringing in senior researchers from elsewhere, but by supporting and nurturing existing staff at all levels and by the appointment of five early career researchers in recent years.
"Our submission also included three highly rated impact case studies: anti-cancer drug design, new therapies for chronic obstructive pulmonary disease (COPD) and ‘next-generation’ oral healthcare products. These three case studies highlight some of the many impacts of our research on society, providing a range of examples to illustrate the success of our impact strategy and the mechanisms for achieving it."
For information on our REF 2014 results, please visit our Featured News page.
- Nucleic Acid Structure and Gene Regulation
- Enzyme Structure and Function
- Protein Structure and Biomedical Science
- Biophysical Methods
Biomaterials and Drug Delivery
- Controlled and targeted drug delivery
- Biomolecular recognition
- Bioadhesion control
Epigenetics and Developmental Biology
- Analysing gene function in development
- Formation of the early axon scaffold
- Interaction between vascularisation and axon outgrowth in the developing brain
- Epigenetics and the role of histone variants
Cell Biology and Pharmacology
- Cellular and Molecular Neuro-oncology
- Inflammation Research
- Mammalian and Fungal ion channels
- Bladder Disease